AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2015
Jul 2, 2015
34931_dirs_2015-07-02_c0a31aec-dd0a-4f77-8000-0ea5369bcf71.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Caladrius Biosciences, Inc. (CLBS)
CIK: 0000320017
Period of Report: 2015-06-30
Reporting Person: Preti Robert A (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-30 | Common Stock, $0.001 par value | A | 1578 | $1.5895 | Acquired | 192584 | Direct |
Footnotes
F1: Shares purchased pursuant to Caladrius Biosciences, Inc.'s 2012 Employee Stock Purchase Plan for the period ended June 30, 2015.